CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- ARS Other Annual Report to Security Holders
- 10-K Report Annual Report
- S-1/A Offering Registration Statement
- 8-K Event Other events
- S-1/A Offering Registration Statement
- 8-K Event Results of operations
- S-1 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 4 Open-market sale 10% owner sold 336,900 shares at an average $3.58 ($1,207,759)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Chief Scientific Officer sold 13,800 shares at $5.03 ($69,370)
- 8-K Event Other events
Page 6 of 19 · 368 filings